한국인의 MCP-1 유전자 다형성과 유전형에 따른 심혈관계질환 위험인자와의 연관성 = Association of MCP-1 polymorphism with cardiovascular disease risk factors in Korean elderly

다국어 초록 (Multilingual Abstract)

Monocyte chemoattractant protein-1 (MCP-1) plays an important role in cardiovascular disease (CVD). Genetic polymorphism in the regulatory regions of MCP-1 could affect MCP-1 expression. The purpose of the study was to explore the possible association of MCP-1 -2518 A/G genetic polymorphism and CVD risk factors in the elderly Korean population. Dietary, anthropometric, and biochemical factors were assessed in 168 subjects. The frequency of A/A, G/A, and G/G genotypes was 14.2%, 45.8%, and 40.0%, respectively. The blood level of MCP-1 was significantly higher in subjects with A/A genotype. The MCP-1 level was significantly higher in A/A genotype with hypercholesterolemia than in other genotypes. Meat intake and percent energy from lipids were significantly positively correlated with the MCP-1 level, especially, stronger in A/A genotype. In the stepwise discriminant analysis, TNF-α level, meat intake, HDL-C were associated with MCP-1 in all subjects (model R2 = 24%). TNF-α level, sugar intake, cholesterol intake, and meat intake affected MCP-1 in A/A genotype (model R2 = 82%), but not in G/A or G/G. In conclusion, subjects possessing A/A genotype exhibited higher levels of MCP-1 than other genotypes in Korean elders. Further, meat, sugar, and cholesterol intakes affected the MCP-1 level. Therefore, the decrement of meat, sugar, and cholesterol intakes helps to normalize the MCP-1 level and can decrease CVD risk in A/A genotype.

참고문헌 (Reference)

1 Shishehbor F, "The effect of low and moderate fat intakes on the postprandial lipaemic and hormonal responses in healthy volunteers" 81 (81): 25-30, 1999

2 Kreijkamp-Kaspers S, "Randomized controlled trial of the effects of soy protein containing isoflavones on vascular function in postmenopausal women" 81 (81): 189-195, 2005

3 Tabara Y, "Polymorphism of the monocyte chemoattractant protein (MCP-1) gene is associated with the plasma level of MCP-1 but not with carotid intima-media thickness" 26 (26): 677-683, 2003

4 Okopień B, "Plasma cytokines as predictors of coronary heart disease" 112 (112): 5-15, 2002

5 The Korean Nutrition Society, Korean Nutrition Information Center, "Nutritional assessment program, ‘CAN pro 3.0’ [CDROM]"

6 Jiang R, "Nut and seed consumption and inflammatory markers in the multi-ethnic study of atherosclerosis" 163 (163): 222-231, 2006

7 Melgarejo E, "Monocyte chemoattractant protein-1: a key mediator in inflammatory processes" 41 (41): 998-1001, 2009

8 Zhong C, "Monocyte chemoattractant protein-1-2518 G/A polymorphism, plasma levels, and premature stable coronary artery disease" 37 (37): 7-12, 2010

9 Pae CU, "Monocyte chemoattractant protein-1 promoter -2518 polymorphism may have an influence on clinical heterogeneity of bipolar I disorder in the Korean population" 49 (49): 111-114, 2004

10 Nelken NA, "Monocyte chemoattractant protein-1 in human atheromatous plaques" 88 (88): 1121-1127, 1991

11 Serrano-Martínez M, "Monocyte chemoattractant protein-1 concentration in coronary sinus blood and severity of coronary disease" 108 (108): e75-, 2003

12 Buraczynska M, "Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for cardiovascular disease in hemodialyzed patients" 44 (44): 361-365, 2008

13 Pola R, "Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism and risk of Alzheimer’s disease in Italians" 39 (39): 1249-1252, 2004

14 김현리, "Monocyte Chemoattractant Protein-1(MCP-1) 조절부위에 따른 유전자다형성이 MCP-1 발현 및낭창성 신염에 미치는 영향" 대한신장학회 21 (21): 18-144, 2002

15 de Lorgeril M, "Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study" 99 (99): 779-785, 1999

16 Aguilar F, "MCP-1 promoter polymorphism in Spanish patients with systemic lupus erythematosus" 58 (58): 335-338, 2001

17 Penz P, "MCP-1 -2518 A/G gene polymorphism is associated with blood pressure in ischemic heart disease asymptomatic subjects" 111 (111): 420-425, 2010

18 Szalai C, "Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients" 158 (158): 233-239, 2001

19 Koh KK, "Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions" 46 (46): 1978-1985, 2005

20 German JB, "Genetic dietetics: nutrigenomics and the future of dietetics practice" 105 (105): 530-531, 2005

21 Ylä-Herttuala S, "Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions" 88 (88): 5252-5256, 1991

22 Franz MJ, "Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications" 25 (25): 148-198, 2002

23 Seli E, "Estradiol down-regulates MCP-1 expression in human coronary artery endothelial cells" 77 (77): 542-547, 2002

24 Friedewald WT, "Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge" 18 (18): 499-502, 1972

25 Cipollone F, "Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty" 21 (21): 327-334, 2001

26 The Korean Nutrition Society, "Dietary reference intakes for Koreans"

27 Sonnenberg L, "Dietary patterns and the metabolic syndrome in obese and nonobese Framingham women" 13 (13): 153-162, 2005

28 Stang J, "Dietary intakes of nutrients thought to modify cardiovascular risk from three groups of American Indians: the Strong Heart Dietary Study, Phase II" 105 (105): 1895-1903, 2005

29 Hu FB, "Dietary fat intake and the risk of coronary heart disease in women" 337 (337): 1491-1499, 1997

30 Tell GS, "Dietary fat intake and carotid artery wall thickness: the Atherosclerosis Risk in Communities (ARIC) Study" 139 (139): 979-989, 1994

31 Tanasescu M, "Dietary fat and cholesterol and the risk of cardiovascular disease among women with type 2 diabetes" 79 (79): 999-1005, 2004

32 Statistics Korea, "Deaths and death rates, In The Cause of Death Statistics 2011"

33 Reape TJ, "Chemokines and atherosclerosis" 147 (147): 213-225, 1999

34 Zietz B, "Caucasian patients with type 2 diabetes mellitus have elevated levels of monocyte chemoattractant protein-1 that are not influenced by the -2518 A-->G promoter polymorphism" 7 (7): 570-578, 2005

35 Ju-young Moon, "Association of Polymorphisms in Monocyte Chemoattractant Protein-1Promoter with Diabetic Kidney Failure in Korean Patients with Type2 Diabetes Mellitus" 대한의학회 22 (22): 810-814, 2007

36 Hyun Jeong Jeon, "Association of Monocyte Chemoattractant Protein-1 (MCP-1) 2518A/G Polymorphism with Proliferative Diabetic Retinopathy in Korean Type 2 Diabetes" 연세대학교의과대학 54 (54): 621-625, 2013

37 Park HJ, "Association of MCP-1 polymorphism with cardiovascular risk factors in Korean elderly" Ewha Womans University 2007

38 de Lemos JA, "Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes" 107 (107): 690-695, 2003

39 Deo R, "Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis" 44 (44): 1812-1818, 2004

40 Kitamoto S, "Anti-monocyte chemoattractant protein-1 gene therapy for cardiovascular diseases" 1 (1): 393-400, 2003

41 Kroner A, "Analysis of the monocyte chemoattractant protein 1 -2518 promoter polymorphism in patients with multiple sclerosis" 64 (64): 70-73, 2004

42 Ozyürek AR, "Allelic frequency of the MCP-1 promoter -2518 polymorphism in the Turkish population and in Turkish patients with juvenile rheumatoid arthritis" 26 (26): 546-550, 2007

43 Rovin BH, "A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression" 259 (259): 344-348, 1999

44 Krüger B, "A monocyte chemoattractant protein-1 (MCP-1) polymorphism and outcome after renal transplantation" 13 (13): 2585-2589, 2002